| Literature DB >> 34207455 |
Paolo Emidio Costantini1, Matteo Di Giosia2, Luca Ulfo1, Annapaola Petrosino1, Roberto Saporetti2, Carmela Fimognari3, Pier Paolo Pompa4, Alberto Danielli1, Eleonora Turrini3, Luca Boselli4, Matteo Calvaresi2.
Abstract
Colorectal cancer (CRC) is a widespread and lethal disease. Relapses of the disease and metastasis are very common in instances of CRC, so adjuvant therapies have a crucial role in its treatment. Systemic toxic effects and the development of resistance during therapy limit the long-term efficacy of existing adjuvant therapeutic approaches. Consequently, the search for alternative strategies is necessary. Photothermal therapy (PTT) represents an innovative treatment for cancer with great potential. Here, we synthesize branched gold nanoparticles (BGNPs) as attractive agents for the photothermal eradication of colon cancer cells. By controlling the NP growth process, large absorption in the first NIR biological window was obtained. The FBS dispersed BGNPs are stable in physiological-like environments and show an extremely efficient light-to-heat conversion capability when irradiated with an 808-nm laser. Sequential cycles of heating and cooling do not affect the BGNP stability. The uptake of BGNPs in colon cancer cells was confirmed using flow cytometry and confocal microscopy, exploiting their intrinsic optical properties. In dark conditions, BGNPs are fully biocompatible and do not compromise cell viability, while an almost complete eradication of colon cancer cells was observed upon incubation with BGNPs and irradiation with an 808-nm laser source. The PTT treatment is characterized by an extremely rapid onset of action that leads to cell membrane rupture by induced hyperthermia, which is the trigger that promotes cancer cell death.Entities:
Keywords: NIR triggering; colon cancer cells; gold nanoparticles; phototheranostics; photothermal therapy; spiky nanoparticles
Year: 2021 PMID: 34207455 PMCID: PMC8233824 DOI: 10.3390/nano11061608
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Figure 1Characterization of BGNPs. (a) TEM micrograph. (b) TEM BGNP size distribution. (c) Vis–NIR absorption spectrum in H2O. (d) DLS analysis (Dh = 164 nm, PDI = 0.06). (e) DCS analysis of BGNP in H2O and cell culture media FBS 50% (apparent sizes of 100 nm and 97 nm respectively). (f) Absorption spectra related to the stability test of BGNPs in biological media: BGNPs were incubated in 50% FBS (in PBS) at 37 °C for different times (1 and 6 h). In the case of anisotropy, DLS and DCS do not represent the actual particle diameter. Consequently, representative particle distributions are reported rather than the actual sizes because of the incorrect geometrical assumption/approximation involved in the measurements.
Figure 2The photothermal effect of BGNPs in a phantom system. (a) Heating curves for different concentrations of BGNPs in water (0.25 mM Au0 in violet, 0.1 mM Au0 in red, 0.05 mM Au0 in blue, 0.025 mM Au0 in green, H2O in yellow) and the BGNP biomolecular corona in water (0.25 mM Au0 in black) during 808 nm NIR laser irradiation (6.6 W cm−2). (b) Thermal imaging of the solution containing BGNPs (0.25 mM Au0) for different times. (c) Temperature change of the solution containing BGNPs (0.25 mM Au0), showing three laser on/off cycles of 808 NIR laser (6.6 W cm−2). The sample was heated for 30 s, then the laser was switched off for 15 min and the solution was left to cool. (d) Vis–NIR spectra of the BGNPs before (black) and after (red) laser irradiation/heating.
Figure 3Flow-cytometric analysis of DLD1 after 24 h of BGNP exposure. (A) Representative gating plot of side scattering (SSC-A) versus forward scattering (FCS-A) of non-treated (NT) cells and BGNP-treated cells with all acquired events (a,b) and gated on living cells (R3) (c,d); (B) representative overlay of a side scattering histogram of cells exposed to BGNP compared to NT cells (dark line); (C) median relative fold-increase of SSC compared to NT cells of four independent experiments. *** p < 0.001 versus NT cells.
Figure 4Confocal microscopy analysis. Representative images showing the XY planes and Z projections for (a,b) DLD1 cells after 24 h of BGNP exposure and (b) untreated DLD1 cell control. Nuclei are visualized by Hoechst staining (blue); BGNPs are visualized by reflected light (red). Bright filed XY transmission images are reported in Figure S3.
Figure 5PTT treatment in colon cancer cells. (a) Percentage of viable cells (MTT) incubated with or without BGNPs, in dark condition or irradiated for different times and laser irradiance determined by MTT test. Percentage of viable cells is normalized on not treated (NT) cells in dark. (b) The percentage of living cells (white), cells undergoing programmed cell-death (red), and necrotic cells (black) after incubation or not with BGNPs in the dark or 3 h, 6 h, and 24 h after 3 min of irradiation at 6.6 W cm−2. Data are the mean values of at least three independent experiments. *** p < 0.001 versus non-treated (NT) cells.